Source: VistaGen Therapeutics, Inc.
Date: December 21, 2006
Summary:
VistaGen Therapeutics Inc., a biopharmaceutical company pioneering the use of embryonic stem cells for the treatment of diabetes and neurological diseases, announced today three recent publications highlighting important advances in the understanding of how embryonic stem cells can be efficiently and reproducibly differentiated into heart and liver cells.
